IP Library Granted Patent US 11,028,115
Granted Patent B2
US 11,028,115 · App. 17/034,725 · Granted Jun 8, 2021

Labelled nucleotides

Inventors: Xiaohai Liu (Cambridge, GB); John Milton (Cambridge, GB); Silke Ruediger (Cambridge, GB); Xiaolin Wu (Cambridge, GB)
Assignee: Illumina Cambridge Limited
C07H19/04C07H19/06C07H19/10C07H19/14C07H19/16C07H19/20C07H21/00C07H21/04C12Q1/6869C12Q1/6874Y10T436/143333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,028,115
App. No.
17/034,725
Granted
Jun 8, 2021
Kind
B2
Abstract

The invention provides a nucleotide or nucleoside having a base attached to a detectable label via a cleavable linker, characterised in that the cleavable linker contains a moiety selected from the group comprising: Formula (I) (wherein X is selected from the group comprising O, S, NH and NQ wherein Q is a C 1-10 substituted or unsubstituted alkyl group, Y is selected from the group comprising O, S, NH and N(allyl), T is hydrogen or a C 1-10 substituted or unsubstituted alkyl group and * indicates where the moiety is connected to the remainder of the nucleotide or nucleoside).

Claims (28)

1. An oligonucleotide comprising a nucleotide residue, wherein said nucleotide residue comprises the structure:

wherein Z is —CH 2 N 3 ;

B is a nucleobase selected from the group consisting of a purine, a pyrimidine and a deazapurine; and

Linker-Label comprises

wherein R is an optionally present electron-withdrawing group; Fluor is a fluorophore; and the dotted line connecting the Fluor and the benzene ring indicates that substitution may be at any free position on the benzene ring and further atoms not shown may be present.

2. The oligonucleotide of claim 1 , wherein R is not present.

3. The oligonucleotide of claim 2 , wherein Linker-Label comprises

4. The oligonucleotide of claim 3 , wherein the dotted line connecting the Fluor and the benzene ring comprises one or more spacer units such that the Fluor is held a sufficient distance from the nucleobase so as not to interfere with any interaction between the nucleotide and an enzyme.

5. The oligonucleotide of claim 4 , wherein the spacer unit comprises —O—, —NH—, or —N(alkyl)-.

6. The oligonucleotide of claim 3 , wherein the Linker-Label comprises:

wherein the double asterisks ** indicates the attachment point to the nucleobase.

7. The oligonucleotide of claim 6 , wherein the Fluor comprises a cyanine, a rhodamine, or a coumarin dye.

8. The oligonucleotide of claim 7 , wherein the Fluor is a rhodamine dye.

9. The oligonucleotide of claim 7 , wherein the Fluor is a Cy5 dye.

10. The oligonucleotide of claim 7 , wherein the Fluor is attached to the Linker by reacting an N-hydroxysuccinimide ester of the Fluor with an amino moiety of the Linker.

11. The oligonucleotide of claim 6 , wherein the nucleobase is

wherein the asterisk * indicates the attachment point to the sugar moiety of the nucleotide residue.

12. The oligonucleotide of claim 11 , wherein the nucleobase is

and the Fluor is a Cy5 dye.

13. The oligonucleotide of claim 11 , wherein the nucleobase is

and the Fluor is a rhodamine dye.

14. The oligonucleotide of claim 6 , wherein the nucleotide residue comprises the structure:

15. The oligonucleotide of claim 6 , wherein the oligonucleotide is in contact with an aqueous solution comprising ethylenediaminetetraacetic acid (EDTA).

16. The oligonucleotide of claim 6 , wherein the oligonucleotide is in contact with a mutant polymerase.

17. The oligonucleotide of claim 6 , wherein the oligonucleotide is in contact with a water soluble phosphine.

18. The oligonucleotide of claim 6 , wherein the oligonucleotide is hybridized to a target polynucleotide, and wherein the target polynucleotide is immobilized to a solid support.

19. The oligonucleotide of claim 18 , wherein the solid support comprises a plurality of immobilized target polynucleotides, wherein at least one immobilized target polynucleotide is hybridized to a second oligonucleotide, and wherein the second oligonucleotide comprises a different fluorophore than the Fluor.

20. The oligonucleotide of claim 19 , the solid support comprises a planar surface.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2020
From: MILTON, JOHN; RUEDIGER, SILKE; LIU, XIAOHAI
To: SOLEXA LIMITED
Reel/Frame 054002/0499 →
CHANGE OF NAME Recorded Oct 7, 2020
From: SOLEXA LIMITED
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 054002/0538 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2020
From: WU, XIAOLIN
To: ILLUMINA CAMBRIDGE LIMITED
Reel/Frame 054002/0564 →
Continuity (10)
Division 16916887 · Jun 30, 2020
Continuation 16691108 · Nov 21, 2019
Continuation 15203562 · Jul 6, 2016
Continuation 14821592 · Aug 7, 2015
Continuation 14073593 · Nov 6, 2013
Continuation 13316204 · Dec 9, 2011
Division 12803163 · Jun 21, 2010
Continuation 12220682 · Jul 24, 2008
Continuation 10525399
Related Publication 20210009622A1 · Jan 14, 2021